Publications by authors named "Alfred Hobisch"

Claim this Profile
S
Sorafenib decreases proliferation and induces apoptosis of prostate cancer cells by inhibition of the androgen receptor and Akt signaling pathways.
Su Jung Oh, Holger H H Erb, Alfred Hobisch, Frédéric R Santer, Zoran Culig

Endocr Relat Cancer· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single institution experience with the transobturator sling suspension system AdVance® in the treatment of male urinary incontinence: mid-term results.
Andreas P Berger, Alexander Strasak, Christian Seitz, Patrick Rein, Alfred Hobisch

Int Braz J Urol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective multicentre study of carboplatin monotherapy for clinical stage I seminoma.
Hannes Steiner, Karl Scheiber, Andreas P Berger, Patrick Rein, Alfred Hobisch

BJU Int· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection and clinical outcome of urinary bladder cancer with 5-aminolevulinic acid-induced fluorescence cystoscopy : A multicenter randomized, double-blind, placebo-controlled trial.
Arnulf Stenzl, Hannes Penkoff, Elfriede Dajc-Sommerer, Andreas Zumbraegel, Lorenz Hoeltl, Alfred Hobisch

Cancer· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SOCS-3 antagonises the proliferative and migratory effects of fibroblast growth factor-2 in prostate cancer by inhibition of p44/p42 MAPK signalling.
Martin Puhr, Frédéric R Santer, Hannes Neuwirt, Gemma Marcias, Alfred Hobisch

Endocr Relat Cancer· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Down-regulation of suppressor of cytokine signaling-3 causes prostate cancer cell death through activation of the extrinsic and intrinsic apoptosis pathways.
Martin Puhr, Frédéric R Santer, Hannes Neuwirt, Martin Susani, Jeffrey A Nemeth, Alfred Hobisch

Cancer Res· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suppressor of cytokine signaling (SOCS)-1 is expressed in human prostate cancer and exerts growth-inhibitory function through down-regulation of cyclins and cyclin-dependent kinases.
Hannes Neuwirt, Martin Puhr, Frédéric R Santer, Martin Susani, Wolfgang Doppler, Alfred Hobisch

Am J Pathol· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptor.
Kamilla Malinowska, Hannes Neuwirt, Ilaria T Cavarretta, Jasmin Bektic, Hannes Steiner, Alfred Hobisch

Endocr Relat Cancer· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Chemotherapy for prostate cancer].
Michael Rauchenwald, Maria De Santis, Eleonore Fink, Wolfgang Höltl, Gero Kramer, Alfred Hobisch

Wien Klin Wochenschr· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oligomeric proanthocyanidin complexes (OPC) exert anti-proliferative and pro-apoptotic effects on prostate cancer cells.
Hannes Neuwirt, Mercedes Cedeno Arias, Martin Puhr, Alfred Hobisch, Zoran Culig

Prostate· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mcl-1 is regulated by IL-6 and mediates the survival activity of the cytokine in a model of late stage prostate carcinoma.
Ilaria Teresa Cavarretta, Hannes Neuwirt, Mohamed H Zaki, Hannes Steiner, Alfred Hobisch

Adv Exp Med Biol· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suppressor of cytokine signalling-3 is up-regulated by androgen in prostate cancer cell lines and inhibits androgen-mediated proliferation and secretion.
Hannes Neuwirt, Martin Puhr, Ilaria T Cavarretta, Michael Mitterberger, Alfred Hobisch

Endocr Relat Cancer· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Posttraumatic high-flow priapism in children: noninvasive treatment by color Doppler ultrasound-guided perineal compression.
Hubert Volgger, Saskia Pfefferkorn, Alfred Hobisch

Urology· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased resistance to trail-induced apoptosis in prostate cancer cells selected in the presence of bicalutamide.
Michael Mitterberger, Hannes Neuwirt, Ilaria T Cavarretta, Alfred Hobisch, Zoran Culig

Prostate· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Androgen deprivation increases p300 expression in prostate cancer cells.
Hannelore V Heemers, Thomas J Sebo, Jose D Debes, Kevin M Regan, Kristin A Raclaw, Alfred Hobisch

Cancer Res· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of growth of prostate cancer cells selected in the presence of interleukin-6 by the anti-interleukin-6 antibody CNTO 328.
Hannes Steiner, Ilaria T Cavarretta, Patrizia L Moser, Andreas P Berger, Jasmin Bektic, Alfred Hobisch

Prostate· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suppressor of cytokine signaling-3 antagonizes cAMP effects on proliferation and apoptosis and is expressed in human prostate cancer.
Ilaria Bellezza, Hannes Neuwirt, Constanze Nemes, Ilaria T Cavarretta, Martin Puhr, Alfred Hobisch

Am J Pathol· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The androgen receptor pathway is by-passed in prostate cancer cells generated after prolonged treatment with bicalutamide.
Alfred Hobisch, Andreas Fritzer, Barbara Comuzzi, Matthias Fiechtl, Kamilla Malinowska

Prostate· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastatic spermatocytic seminoma--an extremely rare disease: Part 2.
Hannes Steiner, Christian Gozzi, Irmgard Verdorfer, Gregor Mikuz, Georg Bartsch, Alfred Hobisch

Eur Urol· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastatic spermatocytic seminoma--an extremely rare disease.
Hannes Steiner, Christian Gozzi, Irmgard Verdorfer, Gregor Mikuz, Georg Bartsch, Alfred Hobisch

Eur Urol· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-6 and oncostatin M stimulation of proliferation of prostate cancer 22Rv1 cells through the signaling pathways of p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase.
Sonia Godoy-Tundidor, Ilaria T R Cavarretta, Dietmar Fuchs, Matthias Fiechtl, Hannes Steiner, Alfred Hobisch

Prostate· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-6 regulation of prostate cancer cell growth.
Zoran Culig, Hannes Steiner, Georg Bartsch, Alfred Hobisch

J Cell Biochem· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression and function of androgen receptor coactivators in prostate cancer.
Zoran Culig, Barbara Comuzzi, Hannes Steiner, Georg Bartsch, Alfred Hobisch

J Steroid Biochem Mol Biol· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The androgen receptor co-activator CBP is up-regulated following androgen withdrawal and is highly expressed in advanced prostate cancer.
Barbara Comuzzi, Constanze Nemes, Stefan Schmidt, Zerina Jasarevic, Michele Lodde, Alfred Hobisch

J Pathol· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate cancer cells generated during intermittent androgen ablation acquire a growth advantage and exhibit changes in epidermal growth factor receptor expression.
Alfred Hobisch, Matthias Fiechtl, Boe Sandahl-Sorensen, Sonia Godoy-Tundidor, Erika Artner-Dworzak

Prostate· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis